Articles Tagged With:
-
Bioterrorism Watch: Anthrax aftermath: Adverse drug reactions, vaccine controversy undercut CDC extended treatment offer
-
Bioterrorism Watch: Side effects undermine anthrax drug adherence
-
Knowledge of home care key for case managers
-
Critical Path Network: Bioterror response requires targeted disaster plan
-
Full March 1, 2002 Issue in PDF
-
Full January 2002 Issue in PDF
-
Updates: Smallpox vaccine trial; D4T phenotypic resistance; VAQTA withdrawal
-
Clinical Briefs in Primary Care Supplement
-
Survey support strong for physician-assisted suicide
-
Full March 1, 2002 Issue in PDF